Jon Kobashigawa

Active 1987–2025

156
Papers
26,030
Citations
85
h-index
150
i10-index

Citations

Citations per year for Jon Kobashigawa1964: 1 citations1989: 1 citations1990: 3 citations1991: 8 citations1992: 6 citations1993: 11 citations1994: 8 citations1995: 20 citations1996: 14 citations1997: 26 citations1998: 23 citations1999: 52 citations2000: 51 citations2001: 52 citations2002: 67 citations2003: 75 citations2004: 94 citations2005: 96 citations2006: 121 citations2007: 124 citations2008: 84 citations2009: 89 citations2010: 139 citations2011: 142 citations2012: 98 citations2013: 120 citations2014: 79 citations2015: 101 citations2016: 98 citations2017: 110 citations2018: 117 citations2019: 562 citations2020: 550 citations2021: 560 citations2022: 500 citations2023: 384 citations2024: 578 citations2025: 251 citations2026: 4 citations1965–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,990 citing papers, 34.8% of this breakdownUnited Kingdom: 365 citing papers, 6.4% of this breakdownCanada: 342 citing papers, 6% of this breakdownGermany: 321 citing papers, 5.6% of this breakdownItaly: 281 citing papers, 4.9% of this breakdownFrance: 222 citing papers, 3.9% of this breakdownChina: 186 citing papers, 3.2% of this breakdownSpain: 183 citing papers, 3.2% of this breakdownNetherlands: 167 citing papers, 2.9% of this breakdownAustralia: 162 citing papers, 2.8% of this breakdownSwitzerland: 149 citing papers, 2.6% of this breakdownBelgium: 125 citing papers, 2.2% of this breakdown
0%34.8%Other 21.5%

Fields

  • Medicine83.5%
  • Biochemistry, Genetics and Molecular Biology6.3%
  • Engineering5.7%
  • Immunology and Microbiology2.6%
  • Health Professions0.3%
  • Computer Science0.3%
  • Other1.3%

Topics

  • Transplantation: Methods and Outcomes15.2%
  • Renal Transplantation Outcomes and Treatments13.4%
  • Organ Transplantation Techniques and Outcomes5.6%
  • Mechanical Circulatory Support Devices5.2%
  • Cardiac Structural Anomalies and Repair2.7%
  • Cardiovascular Function and Risk Factors2%
  • Other55.9%

Coauthors

All papers

Open in search
  1. Report from a consensus conference on primary graft dysfunction after cardiac transplantation

    Authors: , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2014 cited by 777

  2. Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2005 cited by 1,782

  3. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study

    Authors: , , , , , , , , , , , , , - American Journal of Transplantation 2019 cited by 264

  4. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sharon Hunt, Michael Burch, Geetha Bhat, Charles Canter, Richard Chinnock, Marisa Crespo-Leiro, Reynolds M. Delgado, Fabienne Dobbels, Kathleen Grady, Kao W, Jaqueline Lamour, G. Parry, Jignesh Patel, Daniela Pini, Sean Pinney, Jeffrey A. Towbin, Gene Wolfel, Diego Delgado, Howard J. Eisen, Lee R. Goldberg, Jeff Hosenpud, Maryl R. Johnson, Anne Keogh, C. Lewis, John B. OʼConnell, Joseph G. Rogers, Heather Ross, Stuart Russell, Johan Vanhaecke - The Journal of Heart and Lung Transplantation 2010 cited by 1,645

  5. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial

    Authors: , , , , , , , , , , , - The Lancet 2015 cited by 540

  6. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy—2010

    Authors: , , , , , , , , , - The Journal of Heart and Lung Transplantation 2010 cited by 892

  7. Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline G. O’Leary, Scott M. Palmer, Parmjeet Randhawa, John D. Smith, Laurie D. Snyder, Randall C. Starling, Stuart C. Sweet, Timuçin Taner, Craig J. Taylor, E. Steve Woodle, Adriana Zeevi, Peter Nickerson - American Journal of Transplantation 2018 cited by 292

  8. Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management

    Authors: , , , , , , , , , , , , , , , - Circulation 2015 cited by 361

  9. Predicted heart mass is the optimal metric for size match in heart transplantation

    Authors: , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2018 cited by 222

  10. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , - Circulation 2020 cited by 95

  11. Clinical recommendations for posttransplant assessment of anti–HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document

    Authors: , , , , , , , , , , , , , , , , , , - American Journal of Transplantation 2023 cited by 89

  12. Donor heart selection: Evidence-based guidelines for providers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tahir Yağdı, Susan Restaino, Steven Tsui, Daniel Absi, George Sokos, Andreas Zuckermann, Brian Wayda, Joost Felius, Shelley Hall - The Journal of Heart and Lung Transplantation 2022 cited by 129

  13. An overview of frailty in kidney transplantation: measurement, management and future considerations

    Authors: , , , , , , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2020 cited by 120

  14. Report from the American Society of Transplantation on frailty in solid organ transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan G. Tullius, Michael Wilson, Martin R. Zamora, Jennifer C. Lai - American Journal of Transplantation 2018 cited by 236

  15. Assessing and managing frailty in advanced heart failure: An International Society for Heart and Lung Transplantation consensus statement

    Authors: , , , , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2023 cited by 47

  16. Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling

    Authors: , , , , , , , , , , , , , , , , , , - American Journal of Transplantation 2005 cited by 523

  17. Honoring 50 Years of Clinical Heart Transplantation in Circulation

    Authors: , , , , - Circulation 2017 cited by 209

  18. The management of antibodies in heart transplantation: An ISHLT consensus document

    Authors: , , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2018 cited by 160

  19. Cardiac allograft vasculopathy: current review and future research directions

    Authors: , , , , - Cardiovascular Research 2021 cited by 104

  20. Perceptions and Practices Regarding Frailty in Kidney Transplantation: Results of a National Survey

    Authors: , , , , , , , , , , , , , , , , , , , , , - Transplantation 2019 cited by 103

  21. Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center

    Authors: , , , , - International Journal of Heart Failure 2020 cited by 60

  22. Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2003 cited by 1,197

  23. Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , , , , - Circulation 2019 cited by 147

  24. Temporal Trends of De Novo Malignancy Development After Heart Transplantation

    Authors: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 107